Results 41 to 50 of about 9,094,534 (319)

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

Sample genealogies and genetic variation in populations of variable size

open access: yes, 2009
We consider neutral evolution of a large population subject to changes in its population size. For a population with a time-variable carrying capacity we have computed the distributions of the total branch lengths of its sample genealogies.
Eriksson, A.   +3 more
core   +1 more source

Preferences of Pediatric Patients and Their Caregivers for Chemotherapy‐Induced Nausea and Vomiting Control Endpoints: A Mixed Methods Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman   +8 more
wiley   +1 more source

Sample, sample size and sampling: a review of current recommendations

open access: yesInteracciones
Introduction: The present review is based on the need to know the current recommendations on the sample, sample size and sampling that are considered in various empirical studies, aspects that certainly can generate confusion especially in novice ...
José Gamarra-Moncayo   +1 more
doaj   +1 more source

Sample Size Considerations for Hierarchical Populations [PDF]

open access: yesEFSA Journal, 2013
In applied sciences in general, and in particular when dealing with animal health and welfare assessments, one is often confronted with the collection of correlated data (not independent data).
European Food Safety Authority
doaj   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle   +5 more
wiley   +1 more source

Sample size [PDF]

open access: yesJournal of the American Academy of Dermatology, 2018
Deborah Mikyo Oh, Fred Pyrczak
  +5 more sources

Sample Size Determination to Evaluate the Impact of Highway Improvements [PDF]

open access: yes, 1989
This paper was prepared for the Department of Transport, as a support document to a main report on the feasibility of measuring responses to highway improvements.
Fowkes, A.S., Watson, S.M.
core  

Sample Size Effects on the Transport Characteristics of Mesoscopic Graphite Samples

open access: yes, 2008
In this work we investigated correlations between the internal microstructure and sample size (lateral as well as thickness) of mesoscopic, tens of nanometer thick graphite (multigraphene) samples and the temperature $(T)$ and field $(B)$ dependence of ...
Abrikosov   +34 more
core   +1 more source

Home - About - Disclaimer - Privacy